OTC · AMBS
Healthcare · Biotechnology
$0.00
Up+$0.00 (+0.00%)
Updated Oct 7, 2026, 5:02 AM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · AMBS
1M range · 4 trading sessions · Daily adjusted prices
Prices through Oct 1, 2026
AMBS closed at $0.00 after 4 trading sessions.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 1, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 154K |
| Sep 30, 2026 | $0.0001 | $0.0001 | $0.00 | $0.00 | 3.54M |
| Sep 29, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 4.87K |
| Sep 25, 2026 | $0.00 | $0.00 | $0.00 | $0.00 | 227 |
The latest Smart Investors Daily articles mentioning AMBS.
Company
Market Activity
Research & News
AMBS research
Company profile and research snapshot.
AMARANTUS BIOSCIENCE HLDG
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
defenseworld.net · Dec 5, 2025
Amarantus Bioscience (OTCMKTS:AMBS - Get Free Report) and PACS Group (NYSE: PACS - Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, analyst recommendations, earnings and institutional ownership. Analyst Ratings This is a summary of recent
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning AMBS.
No results
No recent SID articles mention AMBS.
